Related references
Note: Only part of the references are listed.rAAV-based brain slice culture models of Alzheimer's and Parkinson's disease inclusion pathologies
Cara L. Croft et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Production of adeno-associated virus vectors for in vitro and in vivo applications
Toyokazu Kimura et al.
SCIENTIFIC REPORTS (2019)
Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies (vol 293, pg 2408, 2018)
Kevin H. Strang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery
Adrienn Volak et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Enhanced Production of Exosome-Associated AAV by Overexpression of the Tetraspanin CD9
Lara Timantra Schiller et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV
Bence Gyorgy et al.
MOLECULAR THERAPY (2017)
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
Ken Y. Chan et al.
NATURE NEUROSCIENCE (2017)
Exosome-associated AAV2 vector mediates robust gene delivery into the murine retina upon intravitreal injection
Sarah J. Wassmer et al.
SCIENTIFIC REPORTS (2017)
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
Nicholas M. Kanaan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau
Kevin H. Strang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Inhibition of glycogen synthase kinase-3 by BTA-EG4 reduces tau abnormalities in an organotypic brain slice culture model of Alzheimer's disease
Cara L. Croft et al.
SCIENTIFIC REPORTS (2017)
Enhanced liver gene transfer and evasion of preexisting humoral immunity with exosome-enveloped AAV vectors
Amine Meliani et al.
BLOOD ADVANCES (2017)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Michael F. Naso et al.
BIODRUGS (2017)
Exosome-associated AAV vector as a robust and convenient neuroscience tool
E. Hudry et al.
GENE THERAPY (2016)
Distribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vector
Bryan A. Piras et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
IFN-γ promotes τ phosphorylation without affecting mature tangles
Andrew Li et al.
FASEB JOURNAL (2015)
IL-10 Alters Immunoproteostasis in APP Mice, Increasing Plaque Burden and Worsening Cognitive Behavior
Paramita Chakrabarty et al.
NEURON (2015)
Comparative Analysis of Cesium Chloride- and Iodixanol-Based Purification of Recombinant Adeno-Associated Viral Vectors for Preclinical Applications
Benjamin Strobel et al.
HUMAN GENE THERAPY METHODS (2015)
Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo
Bence Gyoergy et al.
BIOMATERIALS (2014)
Optimization of the Capsid of Recombinant Adeno-Associated Virus 2 (AAV2) Vectors: The Final Threshold?
George V. Aslanidi et al.
PLOS ONE (2013)
Capsid Serotype and Timing of Injection Determines AAV Transduction in the Neonatal Mice Brain
Paramita Chakrabarty et al.
PLOS ONE (2013)
AAV2/8 Vectors Purified from Culture Medium with a Simple and Rapid Protocol Transduce Murine Liver, Muscle, and Retina Efficiently
Monica Doria et al.
HUMAN GENE THERAPY METHODS (2013)
Microvesicle-associated AAV Vector as a Novel Gene Delivery System
Casey A. Maguire et al.
MOLECULAR THERAPY (2012)
Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors
Steven J. Gray et al.
HUMAN GENE THERAPY (2011)
Activation of the NF-κB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy
Giridhara R. Jayandharan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
Paramita Chakrabarty et al.
FASEB JOURNAL (2010)
Adeno-Associated Virus Serotype 6 Capsid Tyrosine-to-Phenylalanine Mutations Improve Gene Transfer to Skeletal Muscle
Chunping Qiao et al.
HUMAN GENE THERAPY (2010)
Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at Scale
Martin Lock et al.
HUMAN GENE THERAPY (2010)
High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed Tyrosines
David M. Markusic et al.
MOLECULAR THERAPY (2010)
High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2009)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1
Edward B. Miller et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2006)
Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5
M DiMattia et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2005)
Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8
MD Lane et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2005)
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
S Zolotukhin et al.
METHODS (2002)